From advanced wound care through surgery and sports medicine, we are committed to empowering healing by confidently and reliably delivering clinicians the range of regenerative tissue innovations along with the services they need.
Designed for the management of chronic and acute wounds, our portfolio of advanced wound care solutions can support patients from early in the wound healing process through to wound closure—regardless of wound type.

Founded in 2019 and headquartered in Carlisle, PA, Advanced Solution LLC leads the way in regenerative medicine and wound care distribution. Committed to innovation and excellence, the company empowers healthcare providers with turnkey solutions that optimize patient outcomes while maximizing revenue generation. Its flagship programs that offer premium biological products supported by prompt delivery, personalized implementation, and comprehensive clinical tools. Through its proprietary Tissue Vault™ software and FDA-registered Tissue Banks, Advanced Solution streamlines benefit verification, ordering, and logistics, setting the standard for efficiency and reliability. With an unwavering focus on compliance, innovation, and compassion, the company has achieved significant milestones, including the development of cutting-edge logistics infrastructure and the publication of Got Wounds? Wound Care Essentials 101, a cornerstone resource for advanced wound care techniques. Whether serving private practices, government facilities, or hospital systems, Advanced Solution remains a trusted partner dedicated to transforming healthcare delivery. By integrating advanced technologies and expert-driven strategies, Advanced Solution ensures exceptional outcomes for providers and patients alike.

BioLab Holdings is a biotechnology company committed to raising the standard of caring by developing, manufacturing, and commercializing breakthrough products with patient care in mind. At the heart of our work is a mission to optimize the standard of wound care through innovations grounded in science, compassion, and collaboration. We support healthcare distributors, providers, and patients worldwide who share our same initiatives to deliver clinical performance and real-world impact.

Tiger Wound Care is a “first of its kind“ wound care distribution company committed to advancing wound care through innovative and science-driven products.
Tiger Wound Care is a vertically-integrated business, which allows us effectively to bridge the gap between scientific research and real-world medical applications to support clinicians and patients with cutting-edge wound care technologies.
By integrating tissue research, development, clinical expertise, processing, and nationwide distribution under one organization, Tiger Wound Care is successfully able to deliver safe and effective tissue-based products to healthcare providers and patients

Established in 2009, Venture Medical has pioneered novel solutions in wound care including biofilm management, imaging, diagnostics, and biologic allografts, while expanding access to therapies in multiple care environments. Since its beginning as a small group in the Northwest, Venture Medical has grown to manage sales representation across the US, expanded research in
real world settings, and initiated new business models that enable innovative manufacturers to focus on product development and improvements. Interdisciplinary wound care organisation in the US, focused on education, public policy and the application of evidence-based wound care practice. Conceived in 1995, the mission of the AAWC is to advance the care of people with and at risk of wounds

New Horizon Medical Solutions' dedication to patient care sets us apart and drives us to bring high-quality and effective products to healthcare practices across the nation. We are a leading medical device company specializing in biologics and durable medical equipment (DME). Our network includes a diverse range of medical fi elds, such as orthopedic surgery, podiatry, wound care, dermatology, spine, and neurosurgery. Known for our commitment to innovation and excellence, New Horizon Medical Solutions strives to provide top-tier medical products that enhance patient care and improve outcomes

Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. Alongside
our customers we will not settle until we have solved the challenges of preventing and healing wounds, because they hold back too many lives.

AROA is based in Auckland, New Zealand, and has US distribution, sales, and customer services. The company is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. AROA is at the forefront of understanding how biology, structural form, and human factors affect healing and is applying its AROA ECM™ platform technology to unlock regenerative healing for everybody.

At Cellution Biologics, we are a trusted partner in advanced human tissue-based products, driven by a commitment to innovation and a legacy of excellence in placental tissue banking. Leveraging our extensive expertise in tissue processing, we deliver transformative solutions that foster a healthier future.

Convatec has the first and only FDA-cleared placental medical devices for chronic wounds, surgical wounds, and burns with its innovative InnovaMatrix® technology platform - now available in powder form and a variety of membrane sizes. For more information, visit www.innovamatrix.com.

Groundswell Solutions is a value-added distributor of advanced skin substitutes and practice support services, purpose-built for private medical practices. We combine high-performance products with white-glove billing, insurance, and operational support so providers can focus on patient care.
With access to multiple skin substitute options from trusted manufacturers, proprietary workflow software, and dedicated account support, we eliminate friction and bring clarity to complex processes. Our business model is built for stability, with a strong emphasis on compliance, education, and long-term success — for both our provider partners and our team

GR Strategic Advisors is a medical-device and advanced wound-care commercialization firm delivering regulatory, reimbursement, market access, and go-to-market execution. We help global innovators enter the U.S. market, support providers in preventing and mitigating audit risk, and accelerate adoption through policy expertise, data analytics, and hands-on commercialization.

ETS, headquartered in Rolla, Missouri, USA, specializes in developing medical products utilizing proprietary borate-based bioactive glass. Our fl agship product, Mirragen®, represents a breakthrough in wound care technology as the fi rst FDA-cleared inorganic bioactive glass-based solution. Mirragen® is a borate-based bioactive glass fi ber matrix that facilitates quality tissue formation, without the risk of infection that tissue-based products have, all in an easy to use, versatile form factor.

Imbed Biosciences is a privately held medical device company and innovator of SAM™ Antimicrobial Technology, with both commercially available and emerging solutions for the treatment of chronic and acute wounds. Imbed’s revolutionary platform technology enhances skin regeneration by integrating multiple agents into an ultra-thin, biocompatible matrix to facilitate wound healing.

Kent Imaging, a leading innovator in tissue oxygenation assessment, designs and manufactures imaging technology that supports realtime decision-making in wound care, vascular and surgical specialties. Unlike some devices that only measure the macrovasculature, SnapshotNIR utilizes near-infrared light to go below the surface and measure tissue oxygen saturation, oxyhemoglobin, deoxyhemoglobin and total hemoglobin in the microvascular network. Use actionable data to document medical necessity, expedite vascular assessment, design treatment plans, and track and document therapeutic efficacy.

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular-therapy and regenerative-medicine markets. The fatty-acid-rich products from the company’s patented technologies protect the body’s own tissues and enable the body to regenerate tissues. Developed and manufactured in Isafjordur, Iceland, Kerecis medical products are authorized for sale in Europe, the United States. and several other jurisdictions for human-tissue repair. Thousands of patients are treated annually with our technology. And we are broadening our product line to address many more types of soft-tissue damage.

Where Nature Meets Science, Without Compromise Lavior is a pharma company specializing in bio-engineered solutions for skin and wound care. Our clinically proven products support healing of chronic wounds, burns, surgical recovery, and dermatological conditions. Lavior’s proprietary Inula AGS-RIED species, developed from the Inula Viscosa medicinal plant, was created to address the root causes of chronic wound care. Backed by extensive scientific research, this species targets inflammation, infection, and impaired skin repair, the barriers that keep wounds from healing. This proven science powers every Lavior formula. We grow, harvest, extract, and manufacture our wound and skincare products ourselves, ensuring full control, uncompromising quality, and healing solutions that physicians and patients can trust.

Based in Fort Worth, Texas, Legacy Medical is a leader in the supply of advanced wound coverings. We specialize in autologous whole blood clots and amniotic allografts, designed to support patients facing the most challenging chronic wounds.

At Legacy, we believe that clinical excellence and patient advocacy go hand-in-hand. Our team is dedicated to staying at the forefront of medical evidence and regulatory standards to ensure that life-changing treatments remain accessible to everyone who needs them. By combining cutting-edge science with a “people-first” philosophy, we serve as a vital partner to healthcare providers across the country.

From debridement to closure, LifeNet Health offers a portfolio of regenerative wound solutions to help give your patients the healing advantage. Trusted by healthcare professionals worldwide, our solutions are designed to enhance patient outcomes by providing reliable, clinically proven solutions to close wounds with confidence. At LifeNet Health, we want to give healing every advantage. Starting with an ultrasonic debridement system followed by your choice of skin substitutes to help your patient to closure, it's easy to find a solution that fits your needs.

Medaxis is simplifying the world of dynamic wound therapy. Our solutions–including Negative Pressure Wound Therapy and HydroPrep™ Therapy–prepare the wound bed for healing and create an optimal wound healing environment. We are eliminating burdensome processes, simplifying the continuity of care and ushering in a new paradigm in wound therapy.

MIMEDX is a transformational placental biologics company, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental tissue engineering, we have both a commercial business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. MIMEDX has supplied over two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com

MolecuLight delivers an all in one, point of care imaging solution that can detect elevated bacterial loads, accurately measure wounds, and assess temperature variation. Designed for all sites of care and wound types, its FDA-cleared devices combine fluorescence and thermal imaging to transform wound care and drive confident treatment decisions.

Net Health Wound Care Bio: The Net Health Wound Care platform combines a specialty EHR, AI-powered analytics, and patient engagement to help wound care clinics and providers streamline workflows and provide better outcomes for patients and care teams. Our data-driven approach ensures high-quality tools for every clinic.

Reprise Biomedical is focused on the development and commercialization of biological medical devices that offer advanced solutions for wound healing. In 2019, Reprise took ownership of two products, under a proprietary perfusion decellularization technology license from the University of Minnesota, MiroDerm biologic wound matrix for advanced wound management and MiroFlex biologic matrix for soft tissue reinforcement. Reprise is committed to delivering novel solutions which address unmet surgical needs for advanced wound care. Our transformational, Miro3D wound matrix, is an example of that commitment. Miro3D broadens our wound management portfolio by offering a unique three-dimensional solution for deep and tunnelling wounds

ProMed Billing Solutions recognizes the importance of prompt and accurate billing services. We are committed to providing our clients with services that are quicker and more effective than their current processes. Our dedicated staff has over 20 years of iindustry knowledge, experience, and are savvy in WoundCare billing and collections

Sanuwave Health, Inc. is a U.S.-based medical technology company focused on regenerative medicine and advanced wound care. The company develops and commercializes non-invasive, energy-based therapies that stimulate the body’s natural healing processes to repair and regenerate tissue.
Sanuwave’s core technology utilizes low-frequency ultrasound to improve blood flow, promote angiogenesis, and accelerate healing, particularly in chronic and complex wounds. The UltraMIST® System is widely used in hospitals, wound care centers, and clinical settings.

SerenaGroup is a global clinical research organization advancing evidence-based wound care and regenerative medicine. Our mission is to build the world’s leading Comprehensive Wound Care and Research Centers—integrating clinical excellence, scientific rigor, and operational strength.

We drive innovation in wound assessment and clinical practice, translating research into real-world standards of care. SerenaGroup is committed to advancing the science of wound healing and improving outcomes for patients worldwide.

Swift Medical delivers AI-powered digital wound imaging and analytics that enable objective, defensible wound assessment across care settings. The Swift platform combines mobile wound capture with advanced measurement and analytics to support clinical decision-making, operational efficiency, and documentation integrity. With spectral imaging Swift helps providers standardize wound assessment, demonstrate medical necessity, and improve outcomes - in any site of care.

TrueGraft is purpose-built for wound specialists and surgeons, delivering precise wound measurement, patent-pending 3D physical mapping, and intelligent graft size guidance within one seamless mobile platform. Designed to bring certified consistency and calibrated imaging to every encounter, TrueGraft supports clinical, diagnostic, and telemedicine environments with standardized, data-driven accuracy